BridgeMD
New treatment option for Down Syndrome
Official title Measuring Aided Language Development
ClinicalTrials.gov ID: NCT06512168
What this study is testing
- What it's testing
- The focus of the current study is to systematically investigate the psychometric properties of a range of aided language measures, which are based on the Graphic Symbol Utterance and Sentence Development Framework (Binger \& Kent-Walsh).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 42 to 60
You may be able to join if
- Clinical Identification of Down Syndrome or Cerebral Palsy + Significant Speech Impairment
- Must Speak English as a Primary Language
- Must Be Able to Express At Least 25 Words (using any communication mode)
- Must Be Able to Accurately Select Picture Symbols on iPad Communication App with at Least 50% Accuracy
- Vision and Hearing within Functional Limits or Corrected to be within Functional Limits for Study Activities
You likely can't join if
- Clinical Diagnosis of Autism or Social Communication Disorder
- Primary Language Spoken is A Language Other than English
The study team makes the final eligibility decision.
Where it's taking place
- Orlando, Florida, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 42 months to 60 months. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Orlando, Florida, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.